[1] PEARN J.Incidence,prevalence,and gene frequency studies of chronic childhood spinal muscular atrophy[J].J Med Genet,1978,15(6):409-413.
[2] ZHANG X Q,WANG B,ZHANG L C,et al.Accurate diagnosis of spinal muscular atrophy and 22q11.2 deletion syndrome using limited deoxynucleotide triphosphates and high-resolution melting[J].BMC Genomics,2018,19(1):485.
[3] REED U C,ZANOTELI E.Therapeutic advances in 5q-linked spinal muscular atrophy[J].Arq Neuropsiquiatr,2018,76(4):265-272.
[4] 王逸群,刘长云,陈晨,等.儿童脊肌萎缩症的临床分析与基因诊断[J].潍坊医学院学报,2020,42(6):435-438.
[5] MESSINA S,SFRAMELI M.New treatments in spinal muscular atrophy:positive results and new challenges[J].J Clin Med,2020,9(7):2222.
[6] 王柠,何瑾,陈万金.脊髓性肌萎缩症临床诊断研究进展[J].中国现代神经疾病杂志,2012,12(3):252-256.
[7] MARETINA M A,ZHELEZNYAKOVA G Y,LANKO K M,et al.Molecular factors involved in spinal muscular atrophy pathways as possible disease-modifying candidates[J].Curr Genomics,2018,9(5):339-355.
[8] BURGHES A H.When is a deletion not a deletion? When it is converted[J].Am J Hum Genet,1997,61:9-15.
[9] MERTZ L G,CHRISTENSEN R,VOGEL I,et al.Angelman syndrome in Denmark.birth incidence,genetic findings,and age at diagnosis[J].Am J Med Genet A,2013,161A(9):2197-203.
[10] KEHRER-SAWATZKI H,KLUWE L,SANDIG C,et al.High frequency of mosaicism among patients with neurofibromatosis type 1(NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene[J].Am J Hum Genet,2004,75(3):410-423.